ZFAS1 and osteoporosis: This finding suggests that targeting ZFAS1 could be crucial in the treatment of osteoporosis in the elderly, as BMSCs with ZFAS1 knockdown exhibit increased osteogenic differentiation and decreased lipogenic differentiation (Wu et al., 2022).